A detailed history of Virtu Financial LLC transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 27,356 shares of ONTX stock, worth $16,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,356
Holding current value
$16,140
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.57 - $1.0 $15,592 - $27,356
27,356 New
27,356 $12,000
Q4 2022

Feb 15, 2023

SELL
$0.63 - $0.97 $4,069 - $6,266
-6,460 Reduced 27.56%
16,982 $11,000
Q3 2022

Nov 07, 2022

BUY
$0.95 - $1.45 $22,269 - $33,990
23,442 New
23,442 $21,000
Q1 2022

May 17, 2022

SELL
$1.46 - $2.82 $17,563 - $33,924
-12,030 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$2.49 - $3.73 $29,954 - $44,871
12,030 New
12,030 $31,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.